1) experimental aplastic anemia
实验性再生障碍性贫血
1.
Purpose To investigate the promotive effects of synthetic osteogenic growth peptide on hematopoiesis in experimental aplastic anemia (EAA) mice.
目的 研究人工合成成骨生长肽(sOGP)对实验性再生障碍性贫血(EAA)小鼠造血功能恢复的促进作 用。
2) Aplastic anemia
再生障碍性贫血
1.
Death from aplastic anemia and thyroid crisis due to inappropriate treatment with methimazole;
甲巯咪唑治疗不当引起再生障碍性贫血和甲状腺危象导致死亡
2.
Expression of TCR-zeta chain in patients with aplastic anemia and polycythemia vera;
再生障碍性贫血和真性红细胞增多症患者TCRζ链基因表达情况
3.
T-cell suppression mediated by mesenchymal stem cells in patients with chronic aplastic anemia;
慢性再生障碍性贫血患者间充质干细胞对T细胞的抑制作用
3) chronic aplastic anemia
再生障碍性贫血
1.
Effect of Shenfu Injection combined with western medicine on erythrocytes immune function in the treatment for chronic aplastic anemia;
参附注射液配合西药治疗慢性再生障碍性贫血对红细胞免疫功能的影响
2.
Influence of Shenmai injection on blood serum tumor necrosis factor and bone marrow CD_34~(+) cell s apoptosis of chronic aplastic anemia patient;
参麦注射液对慢性再生障碍性贫血患者血清肿瘤坏死因子及骨髓CD_(34)~+细胞凋亡的影响
3.
Clinical efficacy and T-lymphocyte subset, serum interferon-γ(IFN-γ), tumor necrosis factor-α(TNF-α), interleukin-2(IL-2) levels on treatment of chronic aplastic anemia patients by Shenfu injection combined with stanozol and cyclosporin A;
参附注射液配合西药治疗慢性再生障碍性贫血的临床疗效及对免疫功能的影响
4) aplastic anaemia
再生障碍性贫血
1.
Objective Study the effects of sea buckthron oil with apiastic anaemia marrow hematopoiesis of kidney yin and and yang eficiency syndrome, finding out the diffent influentsabout the kidney yin and yang deficiency syndrome, New treat was provided for preventiving and theraping aplastic anaemia, relieving patients economic burdens.
目的： 观察沙棘油对肾阳虚、肾阴虚不同证型再生障碍性贫血患者体外的骨髓单个核细胞干预研究，了解沙棘油对再生障碍性贫血造调节影响，对不同证型再障体外骨髓培养的不同效果，证实中医“阳虚易治，阴虚难调”的理论，为治疗再生障碍性贫血提供新的治疗方法，减轻患者及社会经济负担。
5) aplastic anemia (AA)
再生障碍性贫血(再障)
6) chronic aplastic anemia
慢性再生障碍性贫血
1.
Clinical study on treatment of chronic aplastic anemia with method of invigorating the kidney and marrow;
补肾益髓法治疗慢性再生障碍性贫血临床研究
2.
Study on erythrocyte natural immune activity and plasma IL-6,IL-8and TNF-αlevels in patients with chronic aplastic anemia;
慢性再生障碍性贫血患者红细胞天然免疫活性与血浆IL-6,IL-8和TNF-α水平的研究
3.
The influence of Soluble granules of Bu Sui Sheng xue on IL-1β、IFN-γ、TNF-α expression level of chronic aplastic anemia patients;
补髓生血冲剂对慢性再生障碍性贫血患者造血调控因子表达水平的影响
补充资料：肝炎后再生障碍性贫血
肝炎后再生障碍性贫血
系指肝炎病后发生的再生障碍性贫血。本病临床并不罕见；但发病机理至今尚未明了，可能与肝炎病毒直接抑制骨髓；或通过自身免疫机理，产生抗干细胞的自身抗体；或在肝炎病程中用了对骨髓有毒的药物等因素有关。临床上有两种类型：甲型多见，特点为发病年龄较早，再障多数发生在肝炎后10周内，多处于肝炎恢复期，肝炎症状虽轻，但再障严重，治疗困难，预后不佳。乙型少见，常在慢性肝炎基础上发生，再障可在肝炎后一年以上才发生，发病年龄多在40岁左右，生存期比较长，乙型肝炎抗原可呈阳性反应。本型应针对病因积极给予治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条